Oncology & Cancer

RNA-based therapy brings new hope for an incurable blood cancer

Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, ...

Oncology & Cancer

Many options, good outcomes, for early-stage follicular lymphoma

(Medical Xpress) -- A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient ...

Oncology & Cancer

New understanding of cell metabolism provides therapeutic target

(Medical Xpress) -- One of the reasons that cancer cells proliferate is that they metabolize fuel differently from normal cells.  A team led by Blossom Damania, PhD, at the University of North Carolina at Chapel Hill ...

Oncology & Cancer

Type 2 diabetes linked to increased blood cancer risk

Patients with type 2 diabetes have a 20 percent increased risk of developing blood cancers, such as non-Hodgkin lymphoma, leukemia and myeloma, according to a new meta-analysis led by researchers at The Miriam Hospital. The ...

Oncology & Cancer

New therapy on the horizon for ALK+ non-small cell lung cancer

A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to ...

page 15 from 17